Cargando…
The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach
BACKGROUND: This study aimed to characterize the genetic profile of patients with glioma and discuss the impact of next-generation sequencing in glioma diagnosis and treatment. METHODS: Between 2019 and 2022, we analyzed the genetic profile of 99 patients with glioma through the Oncomine Focus Assay...
Autores principales: | Villani, Veronica, Casini, Beatrice, Tanzilli, Antonio, Lecce, Mario, Rasile, Fabrizio, Telera, Stefano, Pace, Andrea, Piludu, Francesca, Terrenato, Irene, Rollo, Francesca, De Nicola, Francesca, Fanciulli, Maurizio, Pallocca, Matteo, Ciliberto, Gennaro, Carosi, Mariantonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035236/ https://www.ncbi.nlm.nih.gov/pubmed/36959606 http://dx.doi.org/10.1186/s12967-023-04057-y |
Ejemplares similares
-
Coping Style in Glioma Patients and Their Caregiver: Evaluation During Disease Trajectory
por: Guariglia, Lara, et al.
Publicado: (2021) -
Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas
por: Vaccaro, V., et al.
Publicado: (2014) -
A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas
por: Regazzo, Giulia, et al.
Publicado: (2016) -
COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors
por: Tanzilli, Antonio, et al.
Publicado: (2022) -
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
por: Fabi, Alessandra, et al.
Publicado: (2009)